Levetiracetam Cf

Levetiracetam, the active ingredient in Levetiracetam Cf, is an anticonvulsant presented as an oral formulation for oral use. It is employed to control various seizure types in patients with epilepsy, including partial, generalized tonic‑clonic, and myoclonic seizures.

GNH USA supplies Levetiracetam Cf as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers.

Levetiracetam is used in the management of epilepsy, targeting neuronal hyper‑excitability that underlies seizure activity.

- Partial seizures: reduces frequency and severity of focal onset seizures in adults and children. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes in patients with primary generalized epilepsy. - Myoclonic seizures: controls sudden, brief muscle jerks associated with juvenile myoclonic epilepsy. - Adjunctive therapy: can be combined with other antiepileptic drugs when monotherapy is insufficient.

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness - Fatigue - Somnolence - Irritability - Headache - Nausea

Serious or Rare Side Effects: - Severe allergic reactions (e.g., anaphylaxis, Stevens‑Johnson syndrome) - Suicidal thoughts or behavior - Significant skin rash or exfoliative dermatitis - Blood dyscrasias such as neutropenia or thrombocytopenia - Multi‑organ hypersensitivity reactions

Before initiating therapy, consider patient‑specific factors and monitor for potential risks.

- Renal impairment: adjust dose based on creatinine clearance. - Hepatic impairment: monitor liver function and consider dose modification. - Psychiatric symptoms: observe for mood changes, depression, or aggression. - Pregnancy: discuss potential risks with the prescriber; data are limited. - Concomitant CNS depressants: use caution as additive sedation may occur. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Levetiracetam can interact with several medicines, influencing its effectiveness or safety.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma concentrations. - Phenytoin: can reduce levetiracetam levels, decreasing seizure control. - Phenobarbital: may decrease levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance central nervous system depression. - Other antiepileptic drugs: monitor seizure control and possible additive side effects. - Renal excretion inhibitors: observe renal function and adjust dosing if needed.